NCT07103668 2025-10-23
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Suzhou Immunofoco Biotechnology Co., Ltd
Phase 3 Recruiting
Suzhou Immunofoco Biotechnology Co., Ltd
CARsgen Therapeutics Co., Ltd.
Shenzhen BinDeBio Ltd.
Shanghai GeneChem Co., Ltd.